Tumour shrinkage measured with first treatment evaluation under VEGF-targeted therapy as prognostic marker in metastatic renal cell carcinoma (mRCC)

BACKGROUND: The aim of our analysis is to further characterise the prognostic relevance of early tumour shrinkage (TS) during VEGF-targeted therapy in mRCC, in order to explore whether this could define a group of patients with long-term survivorship. METHODS: A hundred patients were stratified into...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Seidel, C, Busch, J, Weikert, S, Steffens, S, Bokemeyer, C, Grünwald, V
Формат: Artigo
Язык:Inglês
Опубликовано: Nature Publishing Group 2013
Предметы:
Clinical Study
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3859945/
https://ncbi.nlm.nih.gov/pubmed/24169357
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2013.662
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы